Constitutive Differential Features of Type 2 Transglutaminase in Cells Derived from Celiac Patients and from Healthy Subjects
Type 2 transglutaminase (TG2) is a ubiquitous enzyme able to modify gliadin peptides introduced into the organism through the diet. By means of its catalytic activity, TG2 seems to have an important pathogenetic role in celiac disease (CD), an inflammatory intestinal disease caused by the ingestion...
Main Authors: | Gaetana Paolella, Merlin Nanayakkara, Silvia Sposito, Marilena Lepretti, Salvatore Auricchio, Carla Esposito, Maria Vittoria Barone, Stefania Martucciello, Ivana Caputo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-02-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/4/1231 |
Similar Items
-
Interplay between Type 2 Transglutaminase (TG2), Gliadin Peptide 31-43 and Anti-TG2 Antibodies in Celiac Disease
by: Stefania Martucciello, et al.
Published: (2020-05-01) -
Celiac Crisis
by: Rômulo Ribeiro do Vale, et al.
Published: (2018-08-01) -
Detection of oral transglutaminases and their relevance in celiac disease
by: Shen, Shiqian
Published: (2018) -
Successes and unsolved problems in the study of celiac disease
by: M F Osipenko, et al.
Published: (2016-02-01) -
Celiac disease detection rate in gastroenterological patients
by: S V Bykova, et al.
Published: (2016-02-01)